Kamila Wójtowicz
Research Subjects
Kamila Wójtowicz has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Wróbel
Second Department of Gynecology, Medical University of Lublin, Jaczewskiego 8 Street, 20-090 Lublin, Poland
3 shared publications - Artur Wdowiak
Department of Obstetrics and Gynecology, Faculty of Health Sciences, Medical University of Lublin, Staszica 4-6 Street, 20-081 Lublin, Poland
3 shared publications - Natalia Wdowiak
Beautiful Smile Clinic, Narutowicza 68 Street, 20-013 Lublin, Poland
3 shared publications - Jan Wróbel
Medical Faculty, Medical University of Lublin, 20-090 Lublin, Poland
2 shared publications - Justyna Kot
Department of Maternal and Child Health, Institute of Nursing and Midwifery, Faculty of Health Sciences, Jagiellonian University Medical College, Kopernika 25 Street, 31-501 Kraków, Poland
2 shared publications - Marta Makara-Studzińska
Faculty of Health Sciences, Jagiellonian University Medical College, Kopernika 25 Street, 31-501 Kraków, Poland
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5086
Depression, Anxiety and Stress Among Women Treated Due to Infertility
Background/Objectives: Infertility is an important public health problem. It is the source of considerable psychological load, negatively affecting the quality of life, social relations, and psychological health. Stress in infertility plays the role of both a risk factor and a consequence of reproductive disorders, exerting an effect through hormonal, inflammatory and oxidative mechanisms, which may reduce the effectiveness of treatment. The aim of the study is assessment of the frequency of occurrence of depression, anxiety, and stress in infertile women. Methods: The study included 300 women treated due to infertility, and 50 women in the control group. The evaluation was carried out using an author-constructed socio-demographic questionnaire and the Depression Anxiety Stress Scales-42 (DASS-42) for the measurement of depression, anxiety, and stress. In addition, selected hormones were determined in blood serum. Results: Hormonal analysis showed significantly higher levels of prolactin (PRL) in women treated due to infertility, especially in the group without the use of assisted reproductive technology (non-ART), whereas higher levels of the follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were noted in the control group. The level of anti-mullerian hormone (AMH) was lower in the therapeutic group, with no differences observed between the methods of treatment, and the levels of thyroid-stimulating hormone (TSH) did not differ between groups. Psychological evaluation according to the DASS-42 showed a significantly higher intensity of depression, anxiety, and stress in patients treated due to infertility, this intensity being the highest in the in vitro fertilization (IVF) group. Weak, but significant, correlations were found between PRL, FSH and LH, and the intensity of the symptoms of depression, anxiety, and stress, and the overall result according to the DASS-42. Conclusions: Infertile women experienced higher levels of depression, anxiety, and stress, compared to fertile women. The study suggests a relationship between the level of psychological stress in persons treated for infertility, and their hormonal status. The study demonstrates that integration of psychological support and infertility treatment may bring about important benefits for psychological health and the quality of life of patients.
- 30 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5086
Open AccessDepression, Anxiety and Stress Among Women Treated Due to Infertility
Background/Objectives: Infertility is an important public health problem. It is the source of considerable psychological load, negatively affecting the quality of life, social relations, and psychological health. Stress in infertility plays the role of both a risk factor and a consequence of reproductive disorders, exerting an effect through hormonal, inflammatory and oxidative mechanisms, which may reduce the effectiveness of treatment. The aim of the study is assessment of the frequency of occurrence of depression, anxiety, and stress in infertile women. Methods: The study included 300 women treated due to infertility, and 50 women in the control group. The evaluation was carried out using an author-constructed socio-demographic questionnaire and the Depression Anxiety Stress Scales-42 (DASS-42) for the measurement of depression, anxiety, and stress. In addition, selected hormones were determined in blood serum. Results: Hormonal analysis showed significantly higher levels of prolactin (PRL) in women treated due to infertility, especially in the group without the use of assisted reproductive technology (non-ART), whereas higher levels of the follicle-stimulating hormone (FSH), and luteinizing hormone (LH) were noted in the control group. The level of anti-mullerian hormone (AMH) was lower in the therapeutic group, with no differences observed between the methods of treatment, and the levels of thyroid-stimulating hormone (TSH) did not differ between groups. Psychological evaluation according to the DASS-42 showed a significantly higher intensity of depression, anxiety, and stress in patients treated due to infertility, this intensity being the highest in the in vitro fertilization (IVF) group. Weak, but significant, correlations were found between PRL, FSH and LH, and the intensity of the symptoms of depression, anxiety, and stress, and the overall result according to the DASS-42. Conclusions: Infertile women experienced higher levels of depression, anxiety, and stress, compared to fertile women. The study suggests a relationship between the level of psychological stress in persons treated for infertility, and their hormonal status. The study demonstrates that integration of psychological support and infertility treatment may bring about important benefits for psychological health and the quality of life of patients.
- Open Access
- 23 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 721
Hormonal Status and Quality of Life of Women Treated for Infertility Before and During COVID-19 Pandemic in Poland
Background/Objectives: Infertile people experience a lot of psychological stress due to the inability to conceive and achieve pregnancy. Studies on the quality of life (QoL) of people undergoing infertility treatment typically show a lower QoL for couples struggling with reproductive problems. In recent years, a new factor that may have had a stressful impact on people treated for infertility is the COVID-19 pandemic. The aim of this study is to assess the impact of the COVID-19 pandemic on the QoL of Polish women treated for infertility and on the secretion of selected sex hormones. Methods: The study sample consisted of 600 women undergoing treatment due to infertility and 100 healthy women in a control group. The World Health Organization Quality of Life-BREF (WHOQOL-BREF) and the Polish version of the questionnaire Fertility Quality of Life (FertiQoL) were used for data collection. The levels of selected hormones were measured from blood samples. Results: The effects of the pandemic were visible primarily in the reduced QoL of patients. The QoL in terms of physical health, psychological health, social relationships, and environmental sphere was drastically reduced by COVID-19, especially among women treated with IVF (in vitro fertilization) and IUI (intrauterine insemination). The hormonal status of women treated for infertility during the pandemic significantly changed due to a decrease in FSH (follicle-stimulating hormone) and LH (luteinizing hormone) secretion and an increase in PRL (prolactin). Conclusions: The pandemic resulted in a decline in the QoL of women with reproductive problems. The quality of life was influenced by the type of therapy used during infertility treatment. The study also suggests a relationship between a decrease in the quality of life of persons treated for infertility during the pandemic and their hormonal status.
- 23 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 721
Open AccessHormonal Status and Quality of Life of Women Treated for Infertility Before and During COVID-19 Pandemic in Poland
Background/Objectives: Infertile people experience a lot of psychological stress due to the inability to conceive and achieve pregnancy. Studies on the quality of life (QoL) of people undergoing infertility treatment typically show a lower QoL for couples struggling with reproductive problems. In recent years, a new factor that may have had a stressful impact on people treated for infertility is the COVID-19 pandemic. The aim of this study is to assess the impact of the COVID-19 pandemic on the QoL of Polish women treated for infertility and on the secretion of selected sex hormones. Methods: The study sample consisted of 600 women undergoing treatment due to infertility and 100 healthy women in a control group. The World Health Organization Quality of Life-BREF (WHOQOL-BREF) and the Polish version of the questionnaire Fertility Quality of Life (FertiQoL) were used for data collection. The levels of selected hormones were measured from blood samples. Results: The effects of the pandemic were visible primarily in the reduced QoL of patients. The QoL in terms of physical health, psychological health, social relationships, and environmental sphere was drastically reduced by COVID-19, especially among women treated with IVF (in vitro fertilization) and IUI (intrauterine insemination). The hormonal status of women treated for infertility during the pandemic significantly changed due to a decrease in FSH (follicle-stimulating hormone) and LH (luteinizing hormone) secretion and an increase in PRL (prolactin). Conclusions: The pandemic resulted in a decline in the QoL of women with reproductive problems. The quality of life was influenced by the type of therapy used during infertility treatment. The study also suggests a relationship between a decrease in the quality of life of persons treated for infertility during the pandemic and their hormonal status.
- Open Access
- 30 September 2024
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 95 (9) , 693-704
Intrauterine deaths — an unsolved problem in Polish perinatology
Objectives: The Polish criteria for “intrauterine death” include fetal demise after 22 weeks of gestation, weighing > 500 g and body length at least 25 cm, when the gestational age is unknown. The rate of fetal death in Poland in 2015 is 3:10,000. In 2020, 1,231 stillbirths were registered. Material and methods: An analysis using 142,662 births in the period between 2015–2020 in 11 living in Poland. The first subgroup was admitted as patients > 22 to the beginning of the 30th week of pregnancy (n = 229), and the second from the 30th week of pregnancy inclusively (n = 179). In the case of women from both subgroups, there was a risk of preterm delivery close to hospitalization. Results: It was found that stillbirth in 41% of women in the first pregnancy. For the patient, stillbirth was also the first in his life. The average stillbirth weight was 1487 g, the average body length was 40 cm. Among fetuses up to 30 weeks, male fetuses are born more often, in subgroup II, the sex of the child was usually female. Most fetal deaths occur in mothers < 15 and > 45 years of age. Conclusions: According to the Polish results of the origin of full-term fetuses > 30 weeks of gestation for death in the concomitant antenatal, such as placental-umbilical and fetal hypoxia, acute intrapartum effects rarely, and moreover < 30 Hbd fetal growth restriction (FGR), occurring placental-umbilical, acute intrapartum often. Objectives: The Polish criteria for “intrauterine death” include fetal demise after 22 weeks of gestation, weighing > 500 g and body length at least 25 cm, when the gestational age is unknown. The rate of fetal death in Poland in 2015 is 3:10,000. In 2020, 1,231 stillbirths were registered. Material and methods: An analysis using 142,662 births in the period between 2015–2020 in 11 living in Poland. The first subgroup was admitted as patients > 22 to the beginning of the 30th week of pregnancy (n = 229), and the second from the 30th week of pregnancy inclusively (n = 179). In the case of women from both subgroups, there was a risk of preterm delivery close to hospitalization. Results: It was found that stillbirth in 41% of women in the first pregnancy. For the patient, stillbirth was also the first in his life. The average stillbirth weight was 1487 g, the average body length was 40 cm. Among fetuses up to 30 weeks, male fetuses are born more often, in subgroup II, the sex of the child was usually female. Most fetal deaths occur in mothers < 15 and > 45 years of age. Conclusions: According to the Polish results of the origin of full-term fetuses > 30 weeks of gestation for death in the concomitant antenatal, such as placental-umbilical and fetal hypoxia, acute intrapartum effects rarely, and moreover < 30 Hbd fetal growth restriction (FGR), occurring placental-umbilical, acute intrapartum often.
- 30 September 2024
- Published by VM Media Group sp. z o.o in Ginekologia Polska
- Vol. 95 (9) , 693-704
Open AccessIntrauterine deaths — an unsolved problem in Polish perinatology
Objectives: The Polish criteria for “intrauterine death” include fetal demise after 22 weeks of gestation, weighing > 500 g and body length at least 25 cm, when the gestational age is unknown. The rate of fetal death in Poland in 2015 is 3:10,000. In 2020, 1,231 stillbirths were registered. Material and methods: An analysis using 142,662 births in the period between 2015–2020 in 11 living in Poland. The first subgroup was admitted as patients > 22 to the beginning of the 30th week of pregnancy (n = 229), and the second from the 30th week of pregnancy inclusively (n = 179). In the case of women from both subgroups, there was a risk of preterm delivery close to hospitalization. Results: It was found that stillbirth in 41% of women in the first pregnancy. For the patient, stillbirth was also the first in his life. The average stillbirth weight was 1487 g, the average body length was 40 cm. Among fetuses up to 30 weeks, male fetuses are born more often, in subgroup II, the sex of the child was usually female. Most fetal deaths occur in mothers < 15 and > 45 years of age. Conclusions: According to the Polish results of the origin of full-term fetuses > 30 weeks of gestation for death in the concomitant antenatal, such as placental-umbilical and fetal hypoxia, acute intrapartum effects rarely, and moreover < 30 Hbd fetal growth restriction (FGR), occurring placental-umbilical, acute intrapartum often. Objectives: The Polish criteria for “intrauterine death” include fetal demise after 22 weeks of gestation, weighing > 500 g and body length at least 25 cm, when the gestational age is unknown. The rate of fetal death in Poland in 2015 is 3:10,000. In 2020, 1,231 stillbirths were registered. Material and methods: An analysis using 142,662 births in the period between 2015–2020 in 11 living in Poland. The first subgroup was admitted as patients > 22 to the beginning of the 30th week of pregnancy (n = 229), and the second from the 30th week of pregnancy inclusively (n = 179). In the case of women from both subgroups, there was a risk of preterm delivery close to hospitalization. Results: It was found that stillbirth in 41% of women in the first pregnancy. For the patient, stillbirth was also the first in his life. The average stillbirth weight was 1487 g, the average body length was 40 cm. Among fetuses up to 30 weeks, male fetuses are born more often, in subgroup II, the sex of the child was usually female. Most fetal deaths occur in mothers < 15 and > 45 years of age. Conclusions: According to the Polish results of the origin of full-term fetuses > 30 weeks of gestation for death in the concomitant antenatal, such as placental-umbilical and fetal hypoxia, acute intrapartum effects rarely, and moreover < 30 Hbd fetal growth restriction (FGR), occurring placental-umbilical, acute intrapartum often.
- Open Access
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1986
Environmental Factors as the Main Hormonal Disruptors of Male Fertility
Introduction and objective: Many scientific reports confirm a systematic decline in male semen parameters over the last decades. This phenomenon has been observed in all parts of the world, and its occurrence is associated, among others, with the hazardous effects of some environmental factors. The environmental factors for which the adverse effect on male fertility has been proven include water, air, and soil pollution, as well as electromagnetic fields and ionizing radiation. The aim of this article was the evaluation of the effect of selected environmental factors on male reproductive capacity based on an analysis of the current scientific reports. Review methods: A systematic literature review was carried out using three databases: PubMed, EMBASE, and Scopus. The search was limited to the period from 2015 until the end of December 2023. Brief description of the state of knowledge: Environmental factors, such as heavy metals, tobacco smoke, pesticides, dioxins, furans, phthalates, and bisphenols, are well-tested substances that exert an adverse effect on male fertility. A harmful effect of electromagnetic fields and water and air pollution on reproductive functions may be expected; however, this has not been fully proven. Summary: Results obtained by many researchers published to date should evoke great concern regarding the quality of the environment in which we live, as well as fears about the effect of environmental factors not only on male fertility, but also on all aspects of human health. The majority of environmental pollutants affect the male body by causing oxidative stress and through their effect on the endocrine system.
- 29 March 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (7) , 1986
Open AccessEnvironmental Factors as the Main Hormonal Disruptors of Male Fertility
Introduction and objective: Many scientific reports confirm a systematic decline in male semen parameters over the last decades. This phenomenon has been observed in all parts of the world, and its occurrence is associated, among others, with the hazardous effects of some environmental factors. The environmental factors for which the adverse effect on male fertility has been proven include water, air, and soil pollution, as well as electromagnetic fields and ionizing radiation. The aim of this article was the evaluation of the effect of selected environmental factors on male reproductive capacity based on an analysis of the current scientific reports. Review methods: A systematic literature review was carried out using three databases: PubMed, EMBASE, and Scopus. The search was limited to the period from 2015 until the end of December 2023. Brief description of the state of knowledge: Environmental factors, such as heavy metals, tobacco smoke, pesticides, dioxins, furans, phthalates, and bisphenols, are well-tested substances that exert an adverse effect on male fertility. A harmful effect of electromagnetic fields and water and air pollution on reproductive functions may be expected; however, this has not been fully proven. Summary: Results obtained by many researchers published to date should evoke great concern regarding the quality of the environment in which we live, as well as fears about the effect of environmental factors not only on male fertility, but also on all aspects of human health. The majority of environmental pollutants affect the male body by causing oxidative stress and through their effect on the endocrine system.
- Open Access
- 27 May 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (11) , 6555
Increased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention
Coronavirus disease—COVID-19 (coronavirus disease 2019) has become the cause of the global pandemic in the last three years. Its etiological factor is SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus type 2). Patients with diabetes (DM—diabetes mellitus), in contrast to healthy people not suffering from chronic diseases, are characterised by higher morbidity and mortality due to COVID-19. Patients who test positive for SARCoV-2 are at higher risk of developing hyperglycaemia. In this paper, we present, analyse and summarize the data on possible mechanisms underlying the increased susceptibility and mortality of patients with diabetes mellitus in the case of SARS-CoV-2 infection. However, further research is required to determine the optimal therapeutic management of patients with diabetes and COVID-19.
- 27 May 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (11) , 6555
Open AccessIncreased Risk of COVID-19 in Patients with Diabetes Mellitus—Current Challenges in Pathophysiology, Treatment and Prevention
Coronavirus disease—COVID-19 (coronavirus disease 2019) has become the cause of the global pandemic in the last three years. Its etiological factor is SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus type 2). Patients with diabetes (DM—diabetes mellitus), in contrast to healthy people not suffering from chronic diseases, are characterised by higher morbidity and mortality due to COVID-19. Patients who test positive for SARCoV-2 are at higher risk of developing hyperglycaemia. In this paper, we present, analyse and summarize the data on possible mechanisms underlying the increased susceptibility and mortality of patients with diabetes mellitus in the case of SARS-CoV-2 infection. However, further research is required to determine the optimal therapeutic management of patients with diabetes and COVID-19.
- Open Access
- 27 April 2022
- Published by Medical Communications Sp. z.o.o. in Journal of Ultrasonography
- Vol. 22 (89) , 100-108
Uterine myomas and sarcomas – clinical and ultrasound characteristics and differential diagnosis using pulsed and color Doppler techniques
Uterine tumors are a challenge encountered by every gynecologist in clinical practice. In the era of increasing incidence of endometrial cancer in the general population of women at reproductive age, compared to other genital malignancies, we should not forget about other tumors originating from the mucous and muscular layer of the uterus. Clear ultrasonographic differentiation of uterine tumors into benign (myomas) and malignant (sarcomas) lesions may sometimes prove impossible. Myomas, the most common uterine tumors, are characterized by discrete vascularization on color Doppler and high blood flow velocity as well as the lack of early diastolic notch on Doppler ultrasound. Sarcomas, on the other hand, show characteristic rich vascularization. Rapid tumor growth should also be noted when making the diagnosis. There are multiple known causes of uterine tumors. So far, no clear Doppler flow markers have been identified to characterize benign and malignant lesions.
- 27 April 2022
- Published by Medical Communications Sp. z.o.o. in Journal of Ultrasonography
- Vol. 22 (89) , 100-108
Open AccessUterine myomas and sarcomas – clinical and ultrasound characteristics and differential diagnosis using pulsed and color Doppler techniques
Uterine tumors are a challenge encountered by every gynecologist in clinical practice. In the era of increasing incidence of endometrial cancer in the general population of women at reproductive age, compared to other genital malignancies, we should not forget about other tumors originating from the mucous and muscular layer of the uterus. Clear ultrasonographic differentiation of uterine tumors into benign (myomas) and malignant (sarcomas) lesions may sometimes prove impossible. Myomas, the most common uterine tumors, are characterized by discrete vascularization on color Doppler and high blood flow velocity as well as the lack of early diastolic notch on Doppler ultrasound. Sarcomas, on the other hand, show characteristic rich vascularization. Rapid tumor growth should also be noted when making the diagnosis. There are multiple known causes of uterine tumors. So far, no clear Doppler flow markers have been identified to characterize benign and malignant lesions.